These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18792862)

  • 1. [Drug eluting stents and anticoagulation in the perioperative setting - an interdisciplinary challenge].
    Preckel B; Schlack W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2008 Sep; 43(9):596-601. PubMed ID: 18792862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradable, drug-eluting stents: a new frontier for the treatment of coronary artery disease.
    Kohn J; Zeltinger J
    Expert Rev Med Devices; 2005 Nov; 2(6):667-71. PubMed ID: 16293093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary artery stents: II. Perioperative considerations and management.
    Newsome LT; Weller RS; Gerancher JC; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):570-90. PubMed ID: 18633036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of the TAXUS Liberté SR paclitaxel-eluting coronary stent.
    Ahmed WH
    Expert Rev Med Devices; 2007 Mar; 4(2):117-20. PubMed ID: 17359218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Position paper on the use of drug eluting stents in coronary heart disease].
    Mudra H; Bode C; Grube E; de Haan F; Levenson B; Schuler G; Silber S; ;
    Z Kardiol; 2004 May; 93(5):416-22. PubMed ID: 15160279
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulatory issues facing the development of drug-eluting stents: a US FDA perspective.
    Boam AB
    Expert Rev Med Devices; 2006 May; 3(3):297-300. PubMed ID: 16681451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug eluting stents.
    Panescu D
    IEEE Eng Med Biol Mag; 2004; 23(2):21-3. PubMed ID: 15264463
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-eluting stents, restenosis and revascularization.
    Ramcharitar S; Gaster AL; Daemen J; Serruys P
    Herz; 2007 Jun; 32(4):287-95. PubMed ID: 17607535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Nordic Bifurcation Study. Randomized study on the question of optimal stenting technique for bifurcating stenosis].
    Herz; 2006 May; 31(3):257. PubMed ID: 17431944
    [No Abstract]   [Full Text] [Related]  

  • 11. Programmable elution profile coating for drug eluting stents.
    Al-Lamee K
    Med Device Technol; 2005 Mar; 16(2):12-5. PubMed ID: 15828493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there any place for oral anti-restenotic treatment in the era of drug eluting stents?
    Gershlick AH
    Heart; 2005 Nov; 91(11):1377-9. PubMed ID: 16230428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary stents: a materials perspective.
    Mani G; Feldman MD; Patel D; Agrawal CM
    Biomaterials; 2007 Mar; 28(9):1689-710. PubMed ID: 17188349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug-eluting coronary stents and drug eluting balloon catheters: summary of the position papers of the DGK].
    Silber S; Borggrefe M; Böhm M; Hoffmeister HM; Dietz R; Ertl G; Heusch G
    Clin Res Cardiol; 2008 Aug; 97(8):548-63. PubMed ID: 18726643
    [No Abstract]   [Full Text] [Related]  

  • 15. Modelling drug elution from stents: effects of reversible binding in the vascular wall and degradable polymeric matrix.
    Borghi A; Foa E; Balossino R; Migliavacca F; Dubini G
    Comput Methods Biomech Biomed Engin; 2008 Aug; 11(4):367-77. PubMed ID: 18568831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do the benefits outweigh the risks with drug-eluting stents?
    Kløw NE
    Scand Cardiovasc J; 2007 Jan; 41(1):8-9. PubMed ID: 17365970
    [No Abstract]   [Full Text] [Related]  

  • 18. The future of CART in the era of drug eluting stents: "It's not over until it's over". Counterpoint.
    Tripuraneni P
    Brachytherapy; 2003; 2(2):74-6. PubMed ID: 15062143
    [No Abstract]   [Full Text] [Related]  

  • 19. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting stent thrombosis.
    Stähli BE; Camici GG; Tanner FC
    Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):45-52. PubMed ID: 19124388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.